首页 | 本学科首页   官方微博 | 高级检索  
     


Risk of adverse events following oseltamivir treatment in influenza outpatients,Vaccine Safety Datalink Project, 2007–2010
Authors:Sharon K. Greene  Lingling Li  David K. Shay  Alicia M. Fry  Grace M. Lee  Steven J. Jacobsen  Roger Baxter  Stephanie A. Irving  Michael L. Jackson  Allison L. Naleway  James D. Nordin  Komal J. Narwaney  Tracy A. Lieu
Affiliation:1. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, , Boston, Massachusetts, USA;2. Influenza Division, Centers for Disease Control and Prevention, , Atlanta, Georgia, USA;3. Division of Infectious Diseases and Department of Laboratory Medicine, Children's Hospital Boston, , Boston, Massachusetts, USA;4. Department of Research and Evaluation, Kaiser Permanente Southern California, , Pasadena, California, USA;5. Kaiser Permanente Vaccine Study Center, , Oakland, California, USA;6. Epidemiology Research Center, Marshfield Clinic Research Foundation, , Marshfield, Wisconsin, USA;7. Group Health Research Institute, , Seattle, Washington, USA;8. Kaiser Permanente Northwest Center for Health Research, , Portland, Oregon, USA;9. HealthPartners Research Foundation, , Minneapolis, Minnesota, USA;10. Institute for Health Research, Kaiser Permanente Colorado, , Denver, Colorado, USA;11. Division of General Pediatrics, Children's Hospital Boston, , Boston, Massachusetts, USA
Abstract:
Keywords:influenza  oseltamivir  adverse events  psychiatric events  matched cohort  propensity scores  pharmacoepidemiology
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号